JAGUAR HEALTH, INC. (JAGX) Gross margin 2016–2025
JAGUAR HEALTH, INC. (JAGX) gross margin by fiscal year — reported gross profit divided by reported revenue.
67.2%FY2025 · since FY2016: 63.3% → 67.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 67.2% | -16.1 pp |
| FY2024 | 83.3% | +4.1 pp |
| FY2023 | 79.1% | -4.0 pp |
| FY2022 | 83.1% | +36.9 pp |
| FY2021 | 46.2% | -18.9 pp |
| FY2020 | 65.1% | +31.1 pp |
| FY2019 | 33.9% | -3.4 pp |
| FY2018 | 37.4% | -42.4 pp |
| FY2017 | 79.8% | +16.5 pp |
| FY2016 | 63.3% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice